Catalog Number UNK_CELSIUS THERMOCOOL |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Pseudoaneurysm (2605)
|
Event Date 12/31/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.Concomitant products that used in this study: non-biosense webster devices that were also used in this study: none manufacturer's ref.No: (b)(4).Biosense webster manufacturer's report numbers: 2029046-2018-02362; 2029046-2018-02363; 2029046-2018-02364.Are related to the same incident.(b)(4).
|
|
Event Description
|
This complaint is from a literature source.The following complications were reported in this publication: 1 patient with arrhythmogenic right ventricular cardiomyopathy underwent catheter ablation of ventricular tachycardia and suffered pseudoaneurysm requiring prolonged mechanical compression.No further details were provided.Per response from the physician the event was not related to biosense webster's products.There are 0 death events and 0 device malfunctions reported in this publication.Model and catalog number are not available, but the suspected device is thermocool other biosense webster devices that were also used in this study: carto.Non-biosense webster devices that were also used in this study: none.Publication details: title: heterogeneous distribution of substrates between the endocardium and epicardium promotes ventricular fibrillation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.Objective: to investigate the prognostic value of scar distribution in patients with arrhythmogenic right ventricular cardiomyopathy (arvc).Methods: between 2008 and 2015, 80 consecutive arvc patients underwent an electrophysiological study with ablation.Thirty-four patients receive both endocardial and epicardial mapping.Abnormal endocardial substrates and epicardial substrates were characterized.".
|
|
Search Alerts/Recalls
|